Ben Derman
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Ben Derman
Jul 14, 2024, 02:56 |
Drugs
Belamaf-based triplet regimens are effective in patients with R/R multiple myeloma - ASCO
ASCO shared on X: "The DREAMM-7 and DREAMM-8 studies established the effectiveness of belamaf-based triplet…
Jun 12, 2024, 05:15 |
Blog
Brand new episode on updates in Myeloma MRD - Blood Cancer Talks
Ben Derman, Assistant Professor at the University of Chicago, recently shared a post by Blood…
May 31, 2024, 09:24 |
Insight
Vincent Rajkumar: International Myeloma Working Group guidelines CAR-T cell treatment in myeloma by Yi Lin
Vincent Rajkumar shared on X: "Just out: International Myeloma Working Group guidelines CAR-T cell treatment…
Apr 18, 2024, 13:58 |
Insight
Ben Derman: Should MRD negativity be accepted as a surrogate endpoint for clinical trials in myeloma
Ben Derman, Assistant Professor at the University of Chicago, shared on X/Twitter: "Should MRD negativity…
Aug 16, 2023, 19:07 |
Drugs
Ben Derman: Some thoughts on Elrantamab in light of approval.
Dr. Ben Derman, Assistant Professor at the University of Chicago, recently shared in a Twitter…
All:
5
Posts:
1 - 100
Immunotherapy vs Chemotherapy: Success Rates, Side Effects, Costs Compared
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube